Treatment of primary chronic cold agglutinin disease with rituximab: maintenance therapy may improve the results
- PMID: 12060148
- DOI: 10.1046/j.1365-2141.2002.03537_6.x
Treatment of primary chronic cold agglutinin disease with rituximab: maintenance therapy may improve the results
Comment on
-
Favourable response to therapy with the anti-CD20 monoclonal antibody rituximab in primary chronic cold agglutinin disease.Br J Haematol. 2001 Oct;115(1):79-83. doi: 10.1046/j.1365-2141.2001.03078.x. Br J Haematol. 2001. PMID: 11722415
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources